Screener
CONMED CNMD Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:MarketingExpense.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | $343,488 | $342,345 | $660,534 | $663,600 |
| Cost of sales(a) | 146,030 | 154,025 | 279,629 | 297,529 |
| Salesforce and commission expense | 59,150 | 58,923 | 117,367 | 116,355 |
| Marketing expense | 19,178 | 16,992 | 37,292 | 32,867 |
| Distribution expense | 14,168 | 13,152 | 27,423 | 25,185 |
| General and administrative expense | 31,143 | 33,016 | 63,537 | 65,670 |
| Stock-based compensation expense | 5,230 | 4,903 | 10,732 | 18,766 |
| Amortization expense | 7,237 | 7,192 | 14,498 | 14,364 |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's sales & marketing?
- CONMED (CNMD) reported sales & marketing of $19.18M in Q2 2026.
- How has CONMED's sales & marketing changed year-over-year?
- CONMED's sales & marketing increased by 12.9% year-over-year, from $16.99M to $19.18M.
- What is the long-term trend for CONMED's sales & marketing?
- Over 3 years (2022 to 2025), CONMED's sales & marketing has grown at a 6.3% compound annual growth rate (CAGR), from $56.03M to $67.25M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about CONMED's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude